Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease

Journal of Clinical Investigation

Volumn 103, Issue 6, 1999, Pages

  Holtzman, David M ^a   Bales, Kelly R ^b   Wu, Shan ^a   Bhat, Priyanka ^a   Parsadanian, Maia ^a   Fagan, Anne M ^a   Chang, Louis K ^a   Sun, Yuling ^a   Paul, Steven M ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; HEMIZYGOSITY; HOMOZYGOSITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

EID: 0033559412     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6179     Document Type: Article

References (60)

1. Mahley, R.W. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:622-630.
2. Plump, A.S., and Breslow, J.L. 1995. Apolipoprotein E and the apolipoprotein E-deficient mouse. Annu. Rev. Nutr. 15:495-518.
3. Newman, T.C., Dawson, P.A., Rudel, L.L., and Williams, D.L. 1985. Quantitation of apolipoprotein E mRNA in the liver and peripheral tissues of nonhuman primates. J. Biol. Chem. 260:2452-2457.
4. Boyles, J.K., Pitas, R.E., Wilson, E., Mahley, R.W., and Taylor, J.M. 1985. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin. Invest. 76:1501-1513.
5. Nakai, M., Kawamata, T., Maeda, K., and Tanaka, C. 1996. Expression of apoE mRNA in rat microglia. Neurosci. Lett. 211:41-44.
6. Stone, D.J., et al. 1997. Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro. Exp. Neurol. 143:313-318.
7. Strittmatter, W.J., and Roses, A.D. 1996. Apolipoprotein E and Alzheimer's disease. Annu. Rev. Nuerosci. 19:53-77.
8. Roses, A.D. 1997. Apolipoprotein E, a gene with complex biological interactions in the aging brain. Neurobiol. Dis. 4:170-186.
9. Strittmatter, W.J., et al. 1993. Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:8098-8102.
10. LaDu, M.J., et al. 1994. Isoform-speciflc binding of apolipoprotein E to β-amyloid. J. Biol. Chem. 269:23404-23406.
11. Ma, J., Yee, A., Brewer, H.B., Das, S., and Potter, H. 1994. Amyloid-associated proteins alpha-1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature. 372:92-94.
12. Sanan, D.A., et al. 1994. Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils. J. Clin. Invest. 94:860-869.
13. Castano, E.M., et al. 1995. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. Biochem. J. 306:599-604.
14. Evans, K.C., Berger, E.P., Cho, C.-G., Weisgraber, K.H., and Lansbury, P.T. 1994. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 92:763-767.
15. Wisniewski, T., and Frangione, B. 1992. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135:235-238.
16. Schmechel, D.E., et al. 1993. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:9649-9653.
17. Rebeck, G.W., Reiter, J.S., Strickland, D.K., and Hyman, B.T. 1993. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron. 11:575-580.
18. Bales, K.R., et al. 1997. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nat. Genet. 17:263-264.
19. Selkoe, D.J. 1997. Alzheimer's disease: genotypes, phenotype, and treatments. Science. 275:630-631.
20. Games, D., et al. 1995. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 373:523-527.
21. Sun, Y., et al. 1998. GFAP-apoE transgenic mice: Astrocyte specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J. Neurosci. 18:3261-3272,
22. Cavalieri, B. 1966. Geometria degli indivisibili. Unione Tipografico. Torino, Italy.
23. Pagan, A.M., Garber, M., Barbacid, M., Silos-Santiago, I., and Holtzman, D.M. 1997. A role for TrkA during maturation of striatal and basal forebrain cholinergic neurons in vivo. J. Neurosci 17:7644-7654.
24. McCall, M.R., Forte, T.M., and Shore, V.G. 1988. Heterogeneity of nascent high density lipoproteins secreted by the hepatoma-derived cell line, Hep G2. J. Lipid Res. 29:1127-1137.
25. Fagan, A.M., Bu, G., Sun, Y., Daugherty, A., and Holtzman, D.M. 1996. Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J. Bioil. Chem. 271:30121-30125.
26. Johnson-Wood, K., et al. 1997. Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 94:1550-1555.
27. Bales, K.R., et al. 1998. Apolipoprotein E and amyloid deposition in transgenic mice. Soc. Neurosci. Abstr. 24:1502. (Abstr.)
28. Sullivan, P.M., et al. 1997. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem. 272:17972-17980.
29. Linton, M.F., et al. 1991. Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J. Clin. Invest. 88:270-281.
30. Biere, A.L., et al. 1995. Co-expression of beta-amyloid precursor protein (betaAPP) and apolipoprotein E in cell culture: analysis of betaAPP processing. Neurobiol. Dis. 2:177-187.
31. Lansbury, P.T.J. 1997. Stuctural neurology: are seeds at the root of neuronal degeneration? Neuron. 19:1151-1154.
32. Wood, S.J., Chan, W., and Wetzel, R. 1996. Seeding of Aβ fibril formation is inhibited by all three isotypes of apolipoprotein E. Biochemistry. 35:12623-12628
33. Roheim, P.S., Carey, M., Forte, T., and Vega, G.L. 1979. Apolipoproteins in human cerebrospinal fluid. Proc. Natl. Acad. Sci. USA. 76:4646-4649.
34. LaDu, M.J., et al. 1998. Nascent astroctye particles differ from lipoproteins in CSF. J. Neurochem. 70:2070-2081
35. Naslund, J., et al. 1995. Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain. Neuron. 15:219-228.
36. Wisniewski, T., Lalowski, M., Golabek, A.A., Vogel, T., and Frangione, B. 1995. Is Alzheimer's disease an apolipoprotein E amyloidosis? Lancet. 345:956-958.
37. Biere, A.L., et al. 1996. Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma. J. Biol. Chem. 271:32916-32922.
38. Koudinov, A.R., Koudinova, N.V., Kumar, A., Beavis, R.C., and Ghiso, J. 1996. Biochemical characterization of Alzheimer's soluble beta protein in human cerebrospinal fluid - association with high density lipoprotein. Biochem. Biophys. Res. Commun. 223:592-597.
39. Swanson, L.W., Simmons, D.M., Hofmann, S.L., Goldstein, J.L. and Brown, M.S. 1988. Localization of mRNA for low density lipoprotein receptor and a cholesterol synthetic enzyme in rabbit nervous system by in situ hybridization. Proc. Natl. Acad. Sci. USA. 85:9821-9825.
40. Kounnas, M.Z., Haudenschild, C.C., Strickland, D.K., and Argraves, W.S. 1994. Immunological localization of glycoprotein 330, low density lipoprotein receptor related protein and 39 kDa receptor associated protein in embryonic mouse tissues. In Vivo. 8:343-351.
41. Christie, R.H., Chung, H., Rebeck, GW., Strickland, D., and Hyman, B.T. 1996. Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55:491-498.
42. Kim, D.H., et al. 1996. Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoportein receptor family predominantly expressed in brain. J. Biol. Chem. 271:8373-8380.
43. Yamazaki, H., et al. 1996. Elements of neural adhesion molecules and a yeast vacuolar protein sorting receptor are present in a novel mammalian low density lipoprotein receptor family member. J. Biol. Chem. 271:24761-24768.
44. Jacobsen, L., et al. 1996. Molecular characterization of a novel human hybrid-type receptor that binds the α2-macroglobulin receptor-associated protein. J. Biol. Chem. 271:31379-31383.
45. Strickland, D.K., et al. 1990. Sequence identity between the α2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J. Biol. Chem. 265:17401-17404.
46. Kounnas, M.Z., et al. 1995. LDL-receptor-related protein, a multifunctional apoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation. Cell. 82:331-340.
47. Kang, D.E., et al. 1997. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology. 49:56-61.
48. Blacker, D., et al. 1998. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat. Genet. 19:357-360.
49. Du, Y., et al. 1997. α2 macroglobulin as a β-amyloid peptide-binding plasma protein. J. Neurochem. 69:299-305.
50. Narita, N., Holtzman, D.M., Schwartz, A.L., and Bu, G. 1997. α2-macroglobulin complexes with and mediates the endocytosis of β-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J. Neurochem. 69:1904-1911.
51. Kowal, R.C., Herz, J., Goldstein J.L., Esser, V., and Brown, M.S. 1989. Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc. Natl. Acad. Sci. USA. 86:5810-5814.
52. Holtzman, D.M., and Fagan, A.M. 1998 Potential role of apoE in structural plasticity in the nervous system: Implications for diseases of the central nervous system. Trends Cardiovasc. Med. 8:250-255.
53. Weisgraber, K.H., and Mahley, R.W. 1996. Human apolipoprotein E: the Alzheimer's disease connection. FASEB J. 10:1485-1494.
54. Ji, Z.S., Pitas, R.E., and Mahley, R.W. 1998. Differential cellular accumulation/retention of apohpoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than E4. J. Biol. Chem. 273:13452-13460.
55. Matsubara, E., Frangione, B., and Ghiso, J. 1995. Characterization of apolipoprotein J Alzheimer's Aβ interaction. J. Biol. Chem. 270:7563-7567.
56. Hammad, S.M., Ranganathan, S., Loukinova, E., Twal, W.O., and Argraves, W.S. 1997. Interaction of apolipoprotein J amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta peptide. J. Biol. Chem. 272:18644-18649.
57. Linton, M.F., Atkinson, J.B., and Fazio, S. 1995. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science. 267:1034-1037.
58. Shimano, H., et al. 1995. Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprorein E in the arterial wall. J Clin. Invest. 95:469-476.
59. Bellosta, S., et al. 1995. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J. Clin. Invest. 96:2170-2179.
60. Fagan, A.M., et al. 1998. Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (-/-) mice but impaired clearance of axonal degeneration products following injury. Exp. Neurol. 151:314-325.